In vivo imaging of muscarinic cholinergic receptors in temporal lobe epilepsy with a new PET tracer: [76Br]4-bromodexetimide

Journal of Nuclear Medicine

Volumn 40, Issue 6, 1999, Pages 935-941

  Dupont, Sophie ^a   Semah, Franck ^b   Loc'h, Christian ^b   Strijckmans, Véronique ^b   Baulac, Michel ^b   Samson, Yves ^b   Mazière, Bernard ^b  

^a DIF   (France)

^b NONE

Author keywords

Bromodexetimide; Muscarinic receptors; PET; Temporal lobe epilepsy

Indexed keywords

4 BROMODEXETIMIDE BR 76; BROMINE; CHOLINERGIC RECEPTOR; DEXETIMIDE; MUSCARINIC RECEPTOR; TRACER; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG DISTRIBUTION; DRUG RECEPTOR BINDING; DRUG UPTAKE; FEMALE; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECEPTOR AFFINITY; TEMPORAL LOBE EPILEPSY;

ADULT; ANIMALS; BROMINE RADIOISOTOPES; CEREBRAL CORTEX; DEXETIMIDE; EPILEPSY, TEMPORAL LOBE; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCARINIC ANTAGONISTS; RADIOPHARMACEUTICALS; RECEPTORS, MUSCARINIC; TEMPORAL LOBE; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0033038086     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Liu Z, Nagao T, Desjardins GC, Gloor P, Avoli M. Quantitative evaluation of neuronal loss in the dorsal hippocampus in rats with long-term pilocarpine seizures. Epilepsy Res. 1994;17:237-247.
2. Brudzynski SM, Cruickshank JW, McLachlan RS. Cholinergic mechanisms in generalized seizures: importance of the zona incerta. Can J Neurol Sci. 1995;22: 115-120.
3. Hoover DB, Craig CR, Colosanti BK. Cholinergic involvement in cobalt-induced epilepsy in the rat. Exp Brain Res. 1977;29:501-513.
4. Green RC, Blume HW, Kupferschmid SB, Mesulam M-M. Alterations of hippocampal acetylcholinesterase in human temporal lobe epilepsy. Ann Neurol. 1989;26:347-351.
5. Kish SJ, Olivier A, Dubeau F, Robitaille Y, Sherwin AL. Increased activity of choline acetyltransferase and acetylcholinesterase in actively epileptic human cerebral cortex. Epilepsy Res. 1988;2:227-231.
6. McNamara JO. Muscarinic cholinergic receptors participate in the kindling model of epilepsy. Brain Res. 1978; 154:415-420.
7. 123M-iododexetimide and single-photon emission computed tomography in epilepsy. Ann Neurol. 1993;34: 235-238.
8. Boundy KL, Rowe CC, Black AB, et al. Localization of temporal lobe epileptic foci with iodine-123 iododexetimide cholinergic neuroreceptor single-photon emission computed tomography. Neurology. 1996;47:1015-1020.
9. Weckesser M, Hufnagel A, Ziemons K, et al. Effect of partial volume correction on muscarinic cholinergic receptor imaging with single-photon emission tomography in patients with temporal epilepsy. Eur J Nucl Med. 1997;24:1156-1161.
10. Adam C, Clemenceau S, Semah F, et al. Variability of presentation in medial temporal lobe epilepsy: a study of 30 operated cases. Acta Neurol Scand. 1996;94:1-11.
11. Ebersole JS, Pacia SV. Localization of temporal lobe foci by ictal EEG patterns. Epilepsia. 1996;37:386-399.
12. Jackson GD, Berkovic SF, Tress BM, Kalnins RM, Fabinyi GC, Bladin PF. Hippocampal sclerosis can be reliably detected by magnetic resonance imaging. Neurology. 1990;40:1869-1875.
13. Theodore WH, Fishbein D, Dubinsky R. Patterns of cerebral glucose metabolism in patients with partial seizures. Neurology. 1988;38:1201-1206.
14. 76[Br]4-bromolevetimide: radiotracers for studying muscarinic cholinergic receptors using PET. J Labelled Compound Radiopharm. 1994;36:259-266.
15. 76Br]bromolevetimide for investigations of central muscarinic cholinergic receptors. Nucl Med Biol. 1996;23:235-243.
16. Mazoyer B, Trebossen R, Deutch R, Casey M, Blohm K. Physical characteristics of the ECAT 953B/31: a new high resolution brain positron tomograph. IEEE Trans Med Imaging. 1991;10:499-504.
17. Beaurain J, Dormont D, Semah F, Hasboun D, Baulac M. Hippocampal formations imaging with axial sections parallel to their longitudinal axis. Magn Reson Imaging. 1994;12:139-148.
18. Semah F, Baulac M, Hasboun D, et al. Is interictal temporal hypometabolism related to mesial temporal sclerosis? A positron emission tomography/magnetic resonance imaging confrontation. Epilepsia. 1995;36:447-456.
19. Cortes R, Palacios JM. Muscarinic cholinergic receptor subtypes in the rat brain. I. Quantitative autoradiographic studies. Brain Res. 1986;362:227-238.
20. Bonner TI, Buckley NJ, Young AC, Brann MR. Identification of a family of muscarinic acetylcholine receptor genes. Science. 1987;237:527-532.
21. Lee J, Paik CH, Kiesewetter DO, Park SG, Eckelman WC. Evaluation of stereoisomers of 4-fluoroalkyl analogues of 3-quinuclidinyl benzilate in in vivo competition studies for the M1, M2, and M3 muscarinic receptor subtypes in brain. Nucl Med Biol. 1995;22:773-781.
22. Cortes R, Probst A, Tobler HJ, Palacios JM. Muscarinic cholinergic receptors subtypes in the human brain. II. Quantitative autoradiographic studies. Brain Res. 1986;362:239-253.
23. Cortes R, Probst A, Palacios JM. Quantitative light microscopic autoradiographic localization of cholinergic muscarinic receptors in the human brain: forebrain. Neuroscience. 1987;20:65-107.
24. Yasuda RP, Ciesla W, Flores LR, et al. Development of antisera selective for m4 and m5 muscarinic cholinergic receptors: distribution of m4 and m5 receptors in rat brain. Mol Pharmacol. 1992;43:149-157.
25. Strijckmans V, Coulon C, Kassiou M, Loc'h C, Mazière B. In vitro pharmacological properties of 4-bromodexetimide for muscarinic receptors. Life Sci. 1996;58: 337-344.
26. Ehlert FJ, Tran LP. Regional distribution of M1, M2 and non-M1, non-M2 subtypes of muscarinic binding sites in rat brain. J Pharmacol Exp Ther. 1990;255:1148-1157.
27. Burdette DE, Sakurai SY, Henry TR, et al. Temporal lobe central benzodiazepine binding in unilateral mesial temporal lobe epilepsy. Neurology. 1995;45:934-941.
28. 18F-FDG positron emission tomography. Neurology. 1993;43:79-86.
29. Henry TR, Mazziotta JC, Engel JJ. Interictal metabolic anatomy of mesial temporal lobe epilepsy. Arch Neurol. 1993;50:582-589.
30. Frey KA, Ciliax B, Agranoff BW. Quantitative in vivo receptor binding. IV: detection of muscarinic receptor down-regulation by equilibrium and by tracer kinetic methods. Neurochem Res. 1991;16:1017-1023.